ESMO Immuno-Oncology Congress

December 13-16, 2018 | Palexpo, Geneva, Switzerland

Event

Your next immuno-oncology breakthrough starts here.

Determining the underlying mechanisms of immunotherapeutic response requires a comprehensive approach to understanding the tumor microenvironment (TME).

At Fluidigm, we enable comprehensive cellular and molecular profiling of the immune system and the tumor microenvironment with proven mass cytometry, Imaging Mass Cytometry™ (IMC™) and automated microfluidics solutions.

Whether you seek to target new biomarkers and pathways or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Fluidigm can help you identify new insights to reach your next research breakthrough.

Visit us at Booth 6

Exhibit Dates and Hours:
Thursday, December 13: 11:00-17:00
Friday, December 14: 8:30-16:30
Saturday, December 14: 8:30-16:30
Sunday, November 15: 8:30-16:30

Listen to presentations featuring Fluidigm technology

Presentations

Thursday, December 13

Time

Title

Presenter, Institution

Session

16:50-17:10 High-dimensional profiling of human antigen-specific T cells: Asking T cells about what they “see” in cancer Evan Newell
SigN, Singapore
Biomarkers

Sunday, December 16

Time

Title

Presenter, Institution

Session

9:30-9:50 Visual a new path forward: Simultaneously detect up to 37 protein markers all from a single scan with Imaging Mass Cytometry Roberto Spada
Fluidigm
Immuno-oncology: State of the Art II
11:00-11:20 Biomarker assessment for other I-O therapy (non-PD1) Kurt Schalper
Yale School of Medicine
Beyond PD-1/PD-L1 axis blockade

Learn about our featured products

Hyperion Imaging System

Comprehensively interrogate complex cellular phenotypes and their interrelationships in the context of the tumor microenvironment with Imaging Mass Cytometry™.

Hyperion Imaging System


Helios

Deeply profile immune and tumor cell populations for phenotype and function, all in a single tube.

Helios, a CyTOF System


Maxpar® panel kits

Simplify and economize immune profiling with the pre-optimized, 29-marker Maxpar® Human Immune Monitoring Panel Kit and a third-party automated data analysis solution.

Human Immune Monitoring Panel Kit


Advanta assays

Reveal the molecular signatures of tumor immune response using the Advanta™ IO Gene Expression Assay on Biomark™ HD and custom assays.

Advanta IO Gene Expression Assay Kit


For Research Use Only. Not for use in diagnostic procedures.